Caesars Acquisition Co. (CACQ) Hits New 52-week Low During February 10 Session

Equities Staff |

Caesars Acquisition Co. (CACQ) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $5.08, Caesars Acquisition Co. dropped to $4.48 for a new 52-week low. By the closing bell, the company's stock was at $5.21 a share for a gain of 3.17%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

Caesars Acquisition Co. saw 119,772 shares of its stock trade hands, that's out of 137.15 million shares outstand. The stock has an average daily volume of 69,419 shares. After hitting a new 52-week low, Caesars Acquisition Co. enters the new trading day with a market cap of 714.57 million, a 50-day SMA of $6.40 and a 200-day SMA of $7.03

Caesars Acquisition Co. now has a P/E ratio of 28.1.

For a complete fundamental analysis analysis of Caesars Acquisition Co., check out Equities.com’s Stock Valuation Analysis report for CACQ. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

Caesars Acquisition Co owns, operates and manages casino entertainment facilities and operates its resorts under the Caesars, Harrah's, & Horseshoe brand names. It operates in two segments; Interactive Entertainment; and Casino Properties & Development.

Caesars Acquisition Co. has 0 employees, is led by CEO Mitchell A. Garber, and makes its home in Las Vegas, NV.

Caesars Acquisition Co. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Valuesetters Inc

Valuesetters Inc is a next generation technology company. The Company is focused in providing technologies and infrastructure-as-a-service (Iaas) to consumer through enterprise communications, entertainment, and game platforms.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.